These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer. Denora N; Laquintana V; Lopalco A; Iacobazzi RM; Lopedota A; Cutrignelli A; Iacobellis G; Annese C; Cascione M; Leporatti S; Franco M J Control Release; 2013 Dec; 172(3):1111-25. PubMed ID: 24096015 [TBL] [Abstract][Full Text] [Related]
3. Bridging Pharmaceutical Chemistry with Drug and Nanoparticle Targeting to Investigate the Role of the 18-kDa Translocator Protein TSPO. Iacobazzi RM; Lopalco A; Cutrignelli A; Laquintana V; Lopedota A; Franco M; Denora N ChemMedChem; 2017 Aug; 12(16):1261-1274. PubMed ID: 28771957 [TBL] [Abstract][Full Text] [Related]
4. The mitochondrial translocator protein (TSPO): a key multifunctional molecule in the nervous system. El Chemali L; Akwa Y; Massaad-Massade L Biochem J; 2022 Jul; 479(13):1455-1466. PubMed ID: 35819398 [TBL] [Abstract][Full Text] [Related]
5. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands. Taliani S; Pugliesi I; Da Settimo F Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396 [TBL] [Abstract][Full Text] [Related]
6. Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand-Dextran Nanogels. Lopalco A; Cutrignelli A; Denora N; Perrone M; Iacobazzi RM; Fanizza E; Lopedota A; Depalo N; de Candia M; Franco M; Laquintana V Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641449 [TBL] [Abstract][Full Text] [Related]
7. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders. Rupprecht R; Papadopoulos V; Rammes G; Baghai TC; Fan J; Akula N; Groyer G; Adams D; Schumacher M Nat Rev Drug Discov; 2010 Dec; 9(12):971-88. PubMed ID: 21119734 [TBL] [Abstract][Full Text] [Related]
8. Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria. Giordani A; Menziani MC; Moresco RM; Matarrese M; Paolino M; Saletti M; Giuliani G; Anzini M; Cappelli A J Med Chem; 2021 Jul; 64(14):9649-9676. PubMed ID: 34254805 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of TSPO ligands on mitochondrial function in mouse microglia cells. Bader S; Wolf L; Milenkovic VM; Gruber M; Nothdurfter C; Rupprecht R; Wetzel CH Psychoneuroendocrinology; 2019 Aug; 106():65-76. PubMed ID: 30954920 [TBL] [Abstract][Full Text] [Related]
10. TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria. Gatliff J; Campanella M Biochem J; 2016 Jan; 473(2):107-21. PubMed ID: 26733718 [TBL] [Abstract][Full Text] [Related]
11. An update into the medicinal chemistry of translocator protein (TSPO) ligands. Barresi E; Robello M; Costa B; Da Pozzo E; Baglini E; Salerno S; Da Settimo F; Martini C; Taliani S Eur J Med Chem; 2021 Jan; 209():112924. PubMed ID: 33081988 [TBL] [Abstract][Full Text] [Related]
12. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
13. Novel irreversible fluorescent probes targeting the 18 kDa translocator protein: synthesis and biological characterization. Taliani S; Da Pozzo E; Bellandi M; Bendinelli S; Pugliesi I; Simorini F; La Motta C; Salerno S; Marini AM; Da Settimo F; Cosimelli B; Greco G; Novellino E; Martini C J Med Chem; 2010 May; 53(10):4085-93. PubMed ID: 20438080 [TBL] [Abstract][Full Text] [Related]
14. Translocator protein (TSPO) in breast cancer. Mukherjee S; Das SK Curr Mol Med; 2012 May; 12(4):443-57. PubMed ID: 22348612 [TBL] [Abstract][Full Text] [Related]
15. Channel-like functions of the 18-kDa translocator protein (TSPO): regulation of apoptosis and steroidogenesis as part of the host-defense response. Veenman L; Papadopoulos V; Gavish M Curr Pharm Des; 2007; 13(23):2385-405. PubMed ID: 17692008 [TBL] [Abstract][Full Text] [Related]
16. [18 kDa translocator protein--implications in cell's functions]. Kołodziejczyk A Postepy Hig Med Dosw (Online); 2015 Jan; 69():34-50. PubMed ID: 25589712 [TBL] [Abstract][Full Text] [Related]
17. A novel conjugable translocator protein ligand labeled with a fluorescence dye for in vitro imaging. Bai M; Wyatt SK; Han Z; Papadopoulos V; Bornhop DJ Bioconjug Chem; 2007; 18(4):1118-22. PubMed ID: 17552492 [TBL] [Abstract][Full Text] [Related]
18. The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production. Danovich L; Veenman L; Leschiner S; Lahav M; Shuster V; Weizman A; Gavish M Eur Neuropsychopharmacol; 2008 Jan; 18(1):24-33. PubMed ID: 17561380 [TBL] [Abstract][Full Text] [Related]
19. Evolving understanding of translocator protein 18 kDa (TSPO). Li F; Liu J; Garavito RM; Ferguson-Miller S Pharmacol Res; 2015 Sep; 99():404-9. PubMed ID: 25882248 [TBL] [Abstract][Full Text] [Related]
20. A self-internalizing mitochondrial TSPO targeting imaging probe for fluorescence, MRI and EM. Samuelson LE; Anderson BM; Bai M; Dukes MJ; Hunt CR; Casey JD; Han Z; Papadopoulos V; Bornhop DJ RSC Adv; 2014; 4(18):9003-9011. PubMed ID: 32051760 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]